Trial Profile
Evaluation of prevalence of erythroblastaemia in multiple sclerosis patients on long-term natalizumab treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary) ; Interferon beta
- Indications Multiple sclerosis
- Focus Adverse reactions
- 11 Dec 2015 New trial record